Debridement and implant retention in the management of hip periprosthetic joint infection: OUTCOMES FOLLOWING GUIDED AND RAPID TREATMENT AT A SINGLE CENTRE

Aims To analyse the effectiveness of debridement and implant retention (DAIR) in patients with hip periprosthetic joint infection (PJI) and the relationship to patient characteristics. The outcome was evaluated in hips with confirmed PJI and a follow‐up of not less than two years. Patients and Methods Patients in whom DAIR was performed were identified from our hip arthroplasty register (between 2004 and 2013). Adherence to criteria for DAIR was assessed according to a previously published algorithm. Results DAIR was performed as part of a curative procedure in 46 hips in 42 patients. The mean age was 73.2 years (44.6 to 87.7), including 20 women and 22 men. In 34 hips in 32 patients (73.9%), PJI was confirmed. In 12 hips, the criteria for PJI were not fulfilled and antibiotics stopped. In 41 (89.1%) of all hips and in 32 (94.1%) of the confirmed PJIs, all criteria for DAIR were fulfilled. In patients with exogenous PJI, DAIR was performed not more than three days after referral. In haematogenous infections, the duration of symptoms did not exceed 21 days. In 28 hips, a single debridement and in six hips two surgical debridements were required. In 28 (87.5%) of 32 patients, the total treatment duration was three months. Failure was noted in three hips (9%). Long‐term follow‐up results (mean 4.0 years, 1.4 to 10) were available in 30 of 34 (88.2%) confirmed PJIs. The overall successful outcome rate was 91% in 34 hips, and 90% in 30 hips with long‐term follow‐up results. Conclusion Prompt surgical treatment with DAIR, following strict diagnostic and therapeutic criteria, in patients with suspected periprosthetic joint infection, can lead to high rates of success in eradicating the infection.

[1]  T. Peel,et al.  Prosthetic Joint Infections , 2018, Springer International Publishing.

[2]  A. O'dowd NHS reports record waiting times in busiest year ever , 2016, British Medical Journal.

[3]  W. Zimmerli,et al.  One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips , 2016, International Orthopaedics.

[4]  P. Stewart Antimicrobial Tolerance in Biofilms , 2015, Microbiology spectrum.

[5]  D. Suvà,et al.  Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus , 2015, International Orthopaedics.

[6]  B. Hintermann,et al.  The treatment and outcome of peri-prosthetic infection of the ankle: a single cohort-centre experience of 34 cases. , 2014, The bone & joint journal.

[7]  M. Dowsey,et al.  Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm‐active antibiotics: functional outcomes, quality of life and complications , 2013, Internal medicine journal.

[8]  A. Hanssen,et al.  Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Hanssen,et al.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Beverland,et al.  Modifiable factors delaying early discharge following primary joint arthroplasty , 2013, European Journal of Orthopaedic Surgery & Traumatology.

[11]  B. Hintermann,et al.  Risk factors for periprosthetic ankle joint infection: a case-control study. , 2012, The Journal of bone and joint surgery. American volume.

[12]  J. Kärrholm,et al.  Increasing risk of prosthetic joint infection after total hip arthroplasty , 2012, Acta orthopaedica.

[13]  C. Romanò,et al.  Value of Debridement and Irrigation for the Treatment of Peri-Prosthetic Infections. A Systematic Review , 2012, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[14]  Heather N. Watson,et al.  Economic burden of periprosthetic joint infection in the United States. , 2012, The Journal of arthroplasty.

[15]  B. Grøgaard,et al.  Early prosthetic joint infections treated with debridement and implant retention , 2012, Acta orthopaedica.

[16]  W. Zimmerli,et al.  Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  M. Clauss,et al.  Fixation and loosening of the cemented Muller straight stem: a long-term clinical and radiological review. , 2009, The Journal of bone and joint surgery. British volume.

[18]  P. Bejon,et al.  One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome , 2009, The Journal of antimicrobial chemotherapy.

[19]  L. Aguilar,et al.  Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. , 2006, The American journal of medicine.

[20]  D. Fisman,et al.  Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Aiono,et al.  Surgeons have little control over general surgical waiting lists. , 2000, Annals of the Royal College of Surgeons of England.

[22]  W. Harmsen,et al.  Risk factors for prosthetic joint infection: case-control study. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .